FDA Inspection 1057831 — Reproductive Medicine Institute
The FDA completed an inspection of Reproductive Medicine Institute on Jun 19, 2018 in Oak Brook, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 19, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Oak Brook, IL (United States)